跳至主要内容
临床试验/NCT02551315
NCT02551315已完成不适用

Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes: the DiabOS Study

University Hospital, Basel, Switzerland5 个研究点 分布在 1 个国家目标入组 274 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
274
试验地点
5
主要终点
Intra-cortical pore volume

研究概览

简要总结

This multicenter, prospective, observational cohort study will assess bone differences in women and men with type 2 diabetes mellitus (T2DM) with and without fragility fractures.

详细描述

Cross-sectional evaluation of clinical, biochemical and microstructural measures of bone in patients with type 2 diabetes and age-matched healthy controls. Longitudinal assessment of clinical, biochemical and microstructural measures of bone in study participants without prevalent fragility fractures.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • presence of type 2 diabetes for at least 3 years (history of treatment for type 2 diabetes)

排除标准

  • immobility
  • coexisting metabolic bone disease or comorbidities affecting bone health
  • previous treatment with osteoporosis medication or intake of medications known to affect bone metabolism (e.g. steroids) within 6 months prior to enrolment
  • thiazolidinedione use

结局指标

主要结局

Intra-cortical pore volume

时间窗: 2 years

Intracortical pore volume using HR-QCT femoral shaft and mid-tibia and HR-pQCT at the distal radius (mm3)

次要结局

  • advanced glycation end products (AGE)(2 years)
  • Occurence of fractures during follow up(2 years)
  • Areal Bone Mineral Density (aBMD)(2 years)
  • Volumetric Bone Mineral Densitiy (vBMD)(2 years)
  • bone turnover markers(2 years)
  • Cortical thickness and porosity(2 years)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christian Meier

Prof. Dr. med.

University Hospital, Basel, Switzerland

研究点 (5)

Loading locations...

相似试验